Improving Care and Reducing Cost Study
ICRC
The Improving Care and Reducing Cost (ICRC) Program
1 other identifier
interventional
461
1 country
8
Brief Summary
The goal of the Improving Care and Reducing Cost (ICRC) Program, is to improve disease management and the overall process of care in treating the chronic illness schizophrenia in order to reduce ER visits and hospital days while providing better care, better health and increased patient satisfaction. This will be done by fostering innovation in the use of technology and by training and deploying a new cadre of personnel in the behavioral health field: Mental Health/Health Technology (MH/HT) Case Managers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable schizophrenia
Started Apr 2013
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 30, 2015
CompletedFirst Posted
Study publicly available on registry
February 18, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedMarch 23, 2017
March 1, 2017
2.2 years
January 30, 2015
March 22, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Total Number of Hospitalization and Emergency Room Visits
Captures the number of hospital and ER visits each month
Baseline, Month 1, Month2, Month 3, Month4, Month 5, and Month 6
Secondary Outcomes (2)
Service Utilization Resource Form
Baseline, month 3, month 6
Change from Baseline Heinrich's Quality of Life Scale
Baseline and month 6
Study Arms (1)
Health Technology Program
OTHERThe components of the treatment model include: 1) Prescriber Decision Assistant (PDA) 2) relapse prevention plan, 3) the daily support website 4) FOCUS, an interactive smart phone text-messaging application 5) a web-based, cognitive-behavioral therapy (CBT) program All patients will be provided with pharmacological treatment (PDA), brief in-person relapse prevention counseling, and an Android mobile phone. The other program components will be provided to patients using a shared decision-making approach to assess need and preference.
Interventions
brief, in-person, relapse prevention counseling with supplemental web-based learning modules,
web-based program for patients and families that provides psychoeducation about schizophrenia and its treatments to improve knowledge, increase problem-solving skills and offer social support through the use of web-based therapist facilitated sessions
A ten-session CBT programs, one to address voices and the other for paranoia. The web-based programs incorporate the essential elements of CBT for psychosis such as normalizing behavior and offering behavioral coping strategies
an interactive smart phone text-messaging application to support medication adherence, facilitate coping with symptoms and improve daily functioning in individuals with schizophrenia
is a web-based prescriber decision support system that includes a brief patient-completed assessment describing symptoms and adverse events which prompts the prescriber to conduct a detailed clinical assessment. Embedded in the program are decision supports for medication choices based on best evidence-based practices regarding symptoms, side effects, information from laboratory tests and history of prior treatment response
Eligibility Criteria
You may qualify if:
- Age 18 to 60, (patients age 51-60 require review from the coordinating site)
- Clinical diagnosis of:
- schizophrenia
- schizoaffective disorder
- psychosis NOS
- Has had two or more inpatient hospitalizations for treatment of a psychotic disorder
- Currently in the hospital or up to 30 days of inpatient hospitalization for a psychotic disorder
- o If patients are sent to a partial, or day hospital following an inpatient hospitalization, the 30 day window begins at the time of discharge from the day or partial hospital
- Any ethnicity
- Ability to participate in research assessments in English
- Ability to provide fully informed consent
You may not qualify if:
- Individuals who cannot understand what research participation entails, or correctly answer the questions about research participation that are part of the Study Information Review and provide fully informed consent will be excluded
- More than 30 days since discharge from a psychiatric hospitalization
- Any other serious medical condition that in the opinion of the investigator would seriously impair functioning making the patient unsuitable for the trial
- Patients who would likely find it burdensome and/or have difficulty sustaining the use of a laptop computer and /or smart phone due to issues of security, consistent connectivity or other factors.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwell Healthlead
- University of Pittsburghcollaborator
- Boston Universitycollaborator
- Dartmouth-Hitchcock Medical Centercollaborator
Study Sites (8)
Henderson Mental Health Center
Fort Lauderdale, Florida, 33319, United States
Community Mental Health Center, Inc.
Lawrenceburg, Indiana, 47025, United States
Cherry Street
Grand Rapids, Michigan, 49503, United States
UMKC School of Pharmacy
Kansas City, Missouri, 64108, United States
Burrell Behavioral Health
Springfield, Missouri, 65802, United States
The Mental Health Center of Greater Manchester
Manchester, New Hampshire, 03101, United States
University of New Mexico Department of Psychiatry UNM Health Sciences Center
Albuquerque, New Mexico, 87131, United States
PeaceHealth Oregon/Lane County Behavioral Health Services
Eugene, Oregon, 97401, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Kane
Northwell Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Vice President, Behavioral Health Services
Study Record Dates
First Submitted
January 30, 2015
First Posted
February 18, 2015
Study Start
April 1, 2013
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
March 23, 2017
Record last verified: 2017-03